Innocenti, F., Owzar, K., Jiang, C., Sibley, A., Niedzwiecki, D., Lenz, H.-J., … McLeod, H. L. (2015). A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. In Journal of Clinical Oncology (Vol. 33, pp. 3599–3599). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3599

Innocenti, Federico, Kouros Owzar, Chen Jiang, Alexander Sibley, Donna Niedzwiecki, Heinz-Josef Lenz, Monica M. Bertagnolli, et al. “A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.” In Journal of Clinical Oncology, 33:3599–3599. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3599.

Innocenti F, Owzar K, Jiang C, Sibley A, Niedzwiecki D, Lenz H-J, et al. A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3599–3599.

Innocenti, Federico, et al. “A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3599–3599. Crossref, doi:10.1200/jco.2015.33.15_suppl.3599.

Innocenti F, Owzar K, Jiang C, Sibley A, Niedzwiecki D, Lenz H-J, Bertagnolli MM, Friedman PN, Furukawa Y, Kubo M, Ratain MJ, Blanke CD, Venook AP, McLeod HL. A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3599–3599.